DMD Gene Variants and Heart Function in Young Males
Part of Bones, joints & muscles, Brain & nervous system, Genetic & congenital, Heart & circulation clinical trials.
This study examines how different genetic changes in the DMD gene affect heart function in boys with dystrophinopathy (a muscle-weakening condition). Understanding this connection may help doctors better monitor and treat heart problems in affected boys.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are male
- You are between 2 and 24 years old
- You have been diagnosed with dystrophinopathy confirmed by a genetic test (such as MLPA, NGS, Sanger sequencing, array-CGH, or qPCR) showing a pathogenic or likely pathogenic change in the DMD gene
- You do not have congenital heart disease, other genetic heart disorders, or other neuromuscular diseases
- You do not have severe high blood pressure, diabetes, or chronic kidney disease that could affect your heart
- Parent or legal guardian consent, and your own assent if age-appropriate
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at heart health in people with Duchenne or Becker muscular dystrophy to find better ways to predict and track heart problems. The goal is to improve future treatment trials.
This study follows women who have a confirmed DMD gene mutation (a genetic change related to Duchenne/Becker muscular dystrophy) to learn more about health and muscle-related measurements. Depending on the part of the study, you may be asked to take part in MRI or other assessments.
This study uses MRI scans and blood or other biomarkers to better understand muscular dystrophy in people with Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD). It may help researchers track disease changes and identify measurable markers over time.
This study tracks development and health in young boys with Duchenne muscular dystrophy during the first three years of life. It aims to better understand early signs and how the condition progresses, which may help improve care and future treatments.
This study looks at genetic causes of inherited heart (cardiovascular) and muscle/nerve (neuromuscular) conditions. You may be asked about your family history and possibly genetic samples to help connect symptoms to specific genetic changes.
This early-phase study tests a new gene therapy called BBM-D101 for boys with Duchenne muscular dystrophy (DMD). The goal is to see if it is safe and helps improve muscle function in young boys.
Hear when a new Becker Muscular Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.